No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Headquartered in Huainan, China, Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. operates within China as a manufacturer and seller of pharmaceutical excipients and specialized medicines. The company's diverse offerings include cellulose, starch, povidone, stearic acid, coating powders, resins, and food additives. Furthermore, it exports these products internationally to regions such as Europe, the United States, and Southeast Asia.
www.shanhe01.comNo one on the platform currently holds 300452.SZ.
No tracked institution reports a position in 300452.SZ as of their last filing.
No one on the platform has traded 300452.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 17.5% | — | — | — | ||
| Rev. Growth % | 6.8% | 12.2% | ||||
| Profit Margin % | 18.7% | 16.9% | 16.9% | |||
| Free Cash Flow Margin % | 16.0% | |||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.0B | +4.1% | $0.82 | $0.82–$0.82 | — | 1 |
| 2027 | $1.1B | +11.1% | $0.92 | $0.92–$0.92 | — | 1 |
| 2028 | $1.3B | +10.6% | $1.04 | $1.04–$1.04 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-24 | $0.12 | $0.21 | +75.0% |
| 2025-04-22 | $0.19 | $0.20 | +5.3% |
| 2024-10-22 | $0.20 | $0.11 | -45.0% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300452.SZAnhui Sunhere Pharmaceutical Excipients Co.,Ltd. | $12.57 | -0.24% | $2.9B | — |
| 000153.SZAnhui Fengyuan Pharmaceutical Co., Ltd. | $5.98 | -0.33% | $2.8B | — |
| 000788.SZPKU HealthCare Corp.,Ltd. | $5.27 | -0.19% | $3.1B | — |
| 002412.SZHunan Hansen Pharmaceutical Co., Ltd. | $8.70 | +0.12% | $4.4B | — |
| 002864.SZShaanxi Panlong Pharmaceutical Group Limited By Share Ltd |
| $20.27 |
| -0.44% |
| $2.8B |
| — |
| 300239.SZBaotou Dongbao Bio-Tech Co.,Ltd | $4.87 | +1.25% | $2.9B | — |
| 300534.SZGansu Longshenrongfa Pharmaceutical Industry CO.,LTD | $12.57 | +0.48% | $3.8B | — |
Source: Financial Modeling Prep · peers by sector/industry